# Intravenous Lidocaine to Reduce Propofol Consumption During Gastroscopy.

> **NCT05944887** · NA · COMPLETED · sponsor: **Erasme University Hospital** · enrollment: 46 (actual)

## Conditions studied

- Diagnostic Gastroscopy

## Interventions

- **DRUG:** Lidocaine 2% Injectable Solution
- **DRUG:** Saline administration as placebo
- **DRUG:** Propofol injection
- **PROCEDURE:** gastroscopy

## Key facts

- **NCT ID:** NCT05944887
- **Lead sponsor:** Erasme University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-21
- **Primary completion:** 2023-08-21
- **Final completion:** 2023-08-25
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2023-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05944887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05944887, "Intravenous Lidocaine to Reduce Propofol Consumption During Gastroscopy.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05944887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*